Biography:

Maxim Rossmann is a Biochemist, Biologist and Biophysicist. He graduated from the Freie Universiatet Berlin in 2002 and obtained his Ph.D. in Biochemistry and Structural Biology from the Institute of Chemistry and Biochemistry, Institute for Crystallography, Freie Universitaet Berlin, Germany. He is a Scientist at the Department of Biochemistry, University of Cambridge, UK and an expert in cell biology, drug discovery and biophysics. Maxim Rossmann is a co-founder and CEO of Cambridge Oncometrix founded in 2012 to develop a novel test for early detection of prostate cancer.